Slingshot members are tracking this event:
Additional Phase 2 Study of CK-2127107 in Patients with COPD Set to Initiate 1H of 2016
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Jun 30, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Ck-2127107, Copd, Chronic Obstructive Pulmonary Disease, Phase 2 Study